Symbols / ACHV $2.67 +0.75% Achieve Life Sciences, Inc.

Healthcare • Biotechnology • United States • NCM
ACHV Chart
About

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 142.15M
Enterprise Value 120.70M Income -54.65M Sales —
Book/sh 0.40 Cash/sh 0.68 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E -2.57 PEG —
P/S — P/B 6.61 P/C —
EV/EBITDA -2.21 EV/Sales — Quick Ratio 4.01
Current Ratio 4.39 Debt/Eq 69.50 LT Debt/Eq —
EPS (ttm) -1.25 EPS next Y -1.04 EPS Growth —
Revenue Growth — Earnings 2026-05-12 ROA -85.30%
ROE -257.67% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 53.24M
Shs Float 47.13M Short Float 15.38% Short Ratio 20.71
Short Interest — 52W High 6.03 52W Low 1.84
Beta 1.83 Avg Volume 576.14K Volume 529.15K
Target Price $14.75 Recom Strong_buy Prev Close $2.65
Price $2.67 Change 0.75%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$14.75
Mean price target
2. Current target
$2.67
Latest analyst target
3. DCF / Fair value
$-9.62
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.67
Low
$10.00
High
$20.00
Mean
$14.75

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-25 reit HC Wainwright & Co. Buy → Buy $12
2025-11-25 init Citizens — → Market Outperform $19
2025-08-21 init HC Wainwright & Co. — → Buy $12
2024-11-14 init Rodman & Renshaw — → Buy $12
2024-08-15 reit Oppenheimer Outperform → Outperform $11
2024-05-13 main Oppenheimer Outperform → Outperform $11
2024-04-17 init JonesTrading — → Buy $20
2024-04-01 reit Oppenheimer Outperform → Outperform $18
2024-03-05 main Lake Street Buy → Buy $11
2023-12-12 main Oppenheimer Outperform → Outperform $18
2023-05-31 main Lake Street Buy → Buy $19
2023-05-10 main Lake Street Buy → Buy $22
2023-03-17 reit Oppenheimer — → Outperform $17
2022-11-16 main Maxim Group — → Buy $8
2021-10-04 init Alliance Global Partners — → Buy $25
2021-06-23 init Oppenheimer — → Outperform $23
2020-09-17 init Lake Street — → Buy $30
2020-02-25 init HC Wainwright & Co. — → Buy $2
2019-06-14 init Maxim Group — → Buy $6
News
RSS: Latest ACHV news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2020-08-18 JACOBS CINDY A Officer — 69 — —
2020-08-18 BENCICH JOHN A Chief Operating Officer — 69 — —
2019-08-13 BENCICH JOHN A Chief Operating Officer — 1,370 — —
2019-06-11 ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security — 264,963 $2.53 $755,856
2019-06-11 ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security — 47,182 $2.85 $134,821
2019-01-15 JACOBS CINDY A Officer — 42 — —
2019-01-15 BENCICH JOHN A Chief Operating Officer — 28 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
39.07
+43.37%
27.25
-33.21%
40.80
+23.29%
33.09
Research And Development
22.82
+44.28%
15.81
-47.42%
30.08
+25.50%
23.97
Selling General And Administration
16.25
+42.11%
11.44
+6.66%
10.72
+17.46%
9.13
General And Administrative Expense
16.25
+42.11%
11.44
+6.66%
10.72
+17.46%
9.13
Other Gand A
16.25
+42.11%
11.44
+6.66%
10.72
+17.46%
9.13
Total Expenses
39.07
+43.37%
27.25
-33.21%
40.80
+23.29%
33.09
Operating Income
-39.07
-43.37%
-27.25
+33.21%
-40.80
-23.29%
-33.09
EBITDA
-37.42
-39.96%
-26.73
+33.70%
-40.33
-22.56%
-32.90
Normalized EBITDA
-36.51
-39.33%
-26.21
+35.01%
-40.33
-22.56%
-32.90
Reconciled Depreciation
0.23
+0.44%
0.23
-3.39%
0.24
-5.60%
0.25
EBIT
-37.65
-39.63%
-26.96
+33.53%
-40.56
-22.35%
-33.15
Total Unusual Items
-0.90
-71.21%
-0.53
0.00
0.00
Total Unusual Items Excluding Goodwill
-0.90
-71.21%
-0.53
0.00
0.00
Special Income Charges
-0.90
-71.21%
-0.53
0.00
0.00
Other Special Charges
0.28
—
—
—
Restructuring And Mergern Acquisition
0.62
+17.61%
0.53
0.00
0.00
Net Income
-39.83
-33.58%
-29.82
+29.60%
-42.35
-27.74%
-33.15
Pretax Income
-39.83
-33.58%
-29.82
+29.60%
-42.35
-27.74%
-33.15
Net Non Operating Interest Income Expense
0.18
+108.68%
-2.03
-27.55%
-1.59
-9452.94%
0.02
Interest Expense Non Operating
2.18
-23.59%
2.85
+59.47%
1.79
0.00
Net Interest Income
0.18
+108.68%
-2.03
-27.55%
-1.59
-9452.94%
0.02
Interest Expense
2.18
-23.59%
2.85
+59.47%
1.79
0.00
Interest Income Non Operating
2.36
+185.58%
0.82
+314.57%
0.20
+1070.59%
0.02
Interest Income
2.36
+185.58%
0.82
+314.57%
0.20
+1070.59%
0.02
Other Income Expense
-0.93
-73.93%
-0.54
-1442.50%
0.04
+153.33%
-0.07
Other Non Operating Income Expenses
-0.03
-233.33%
-0.01
-122.50%
0.04
+153.33%
-0.07
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-39.83
-33.58%
-29.82
+29.60%
-42.35
-27.74%
-33.15
Net Income From Continuing Operation Net Minority Interest
-39.83
-33.58%
-29.82
+29.60%
-42.35
-27.74%
-33.15
Net Income From Continuing And Discontinued Operation
-39.83
-33.58%
-29.82
+29.60%
-42.35
-27.74%
-33.15
Net Income Continuous Operations
-39.83
-33.58%
-29.82
+29.60%
-42.35
-27.74%
-33.15
Normalized Income
-38.92
-32.90%
-29.29
+30.85%
-42.35
-27.74%
-33.15
Net Income Common Stockholders
-39.83
-33.58%
-29.82
+29.60%
-42.35
-27.74%
-33.15
Diluted EPS
-1.24
+17.33%
-1.50
+62.50%
-4.00
+1.96%
-4.08
Basic EPS
-1.24
+17.33%
-1.50
+62.50%
-4.00
+1.96%
-4.08
Basic Average Shares
32.07
+61.75%
19.83
+87.17%
10.59
+30.46%
8.12
Diluted Average Shares
32.07
+61.75%
19.83
+87.17%
10.59
+30.46%
8.12
Diluted NI Availto Com Stockholders
-39.83
-33.58%
-29.82
+29.60%
-42.35
-27.74%
-33.15
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
38.63
+99.44%
19.37
-35.37%
29.97
-36.92%
47.52
Current Assets
36.47
+114.74%
16.98
-37.86%
27.33
-38.71%
44.59
Cash Cash Equivalents And Short Term Investments
34.34
+121.61%
15.50
-37.32%
24.72
-42.54%
43.02
Cash And Cash Equivalents
12.73
-17.83%
15.50
-37.32%
24.72
-42.54%
43.02
Cash Equivalents
12.13
-14.85%
14.25
-37.37%
22.76
-45.64%
41.86
Cash Financial
0.60
-51.93%
1.24
-36.69%
1.97
+68.96%
1.16
Other Short Term Investments
21.61
0.00
—
—
Receivables
0.00
-100.00%
0.11
+5.71%
0.10
-31.37%
0.15
Other Receivables
—
0.11
+5.71%
0.10
-31.37%
0.15
Prepaid Assets
—
—
—
1.42
Restricted Cash
0.02
-60.00%
0.05
+0.00%
0.05
—
Other Current Assets
2.11
+59.02%
1.32
-46.01%
2.45
+72.94%
1.42
Total Non Current Assets
2.17
-9.33%
2.39
-9.54%
2.64
-9.62%
2.92
Net PPE
0.12
+80.30%
0.07
-46.34%
0.12
+92.19%
0.06
Gross PPE
0.12
+80.30%
0.07
-46.34%
0.12
+92.19%
0.06
Accumulated Depreciation
—
—
-0.30
-4.18%
-0.29
Properties
—
—
0.00
0.00
Machinery Furniture Equipment
—
—
0.26
+0.78%
0.26
Other Properties
0.12
+80.30%
0.07
-46.34%
0.12
+92.19%
0.06
Leases
—
—
0.03
-3.85%
0.03
Goodwill And Other Intangible Assets
2.01
-10.00%
2.23
-9.01%
2.45
-8.34%
2.67
Goodwill
1.03
+0.00%
1.03
+0.00%
1.03
+0.00%
1.03
Other Intangible Assets
0.97
-18.63%
1.20
-15.59%
1.42
-13.59%
1.64
Other Non Current Assets
0.04
-57.61%
0.09
+39.39%
0.07
-63.93%
0.18
Total Liabilities Net Minority Interest
17.73
-14.82%
20.82
-3.92%
21.67
+11.27%
19.47
Current Liabilities
6.68
-67.90%
20.81
-3.64%
21.60
+374.70%
4.55
Payables And Accrued Expenses
3.60
+188.23%
1.25
-67.06%
3.79
+49.23%
2.54
Payables
1.95
+215.53%
0.62
-62.77%
1.66
+97.38%
0.84
Accounts Payable
1.95
+215.53%
0.62
-62.77%
1.66
+97.38%
0.84
Current Accrued Expenses
1.65
+161.49%
0.63
-70.40%
2.13
+25.41%
1.70
Pensionand Other Post Retirement Benefit Plans Current
3.03
+30.98%
2.31
+37.72%
1.68
-13.51%
1.94
Current Debt And Capital Lease Obligation
0.06
-99.67%
16.73
+3.70%
16.13
+23275.36%
0.07
Current Debt
—
16.66
+3.68%
16.07
—
Other Current Borrowings
—
16.66
+3.68%
16.07
—
Current Capital Lease Obligation
0.06
-12.70%
0.06
+8.62%
0.06
-15.94%
0.07
Other Current Liabilities
—
0.53
—
—
Total Non Current Liabilities Net Minority Interest
11.05
+184100.00%
0.01
-91.30%
0.07
-99.54%
14.92
Long Term Debt And Capital Lease Obligation
9.90
+164950.00%
0.01
-91.30%
0.07
-99.54%
14.92
Long Term Debt
9.84
—
—
14.92
Long Term Capital Lease Obligation
0.07
+1000.00%
0.01
-91.30%
0.07
+1625.00%
0.00
Other Non Current Liabilities
1.15
—
—
—
Stockholders Equity
20.90
+1543.30%
-1.45
-117.44%
8.30
-70.39%
28.04
Common Stock Equity
20.90
+1543.30%
-1.45
-117.44%
8.30
-70.39%
28.04
Capital Stock
0.10
+14.44%
0.09
+3.45%
0.09
+10.13%
0.08
Common Stock
0.10
+14.44%
0.09
+3.45%
0.09
+10.13%
0.08
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
34.69
+63.87%
21.17
+18.26%
17.90
+89.32%
9.45
Ordinary Shares Number
34.69
+63.87%
21.17
+18.26%
17.90
+89.32%
9.45
Additional Paid In Capital
226.34
+37.84%
164.21
+13.92%
144.15
+18.60%
121.55
Retained Earnings
-205.58
-24.03%
-165.75
-21.93%
-135.94
-45.25%
-93.59
Gains Losses Not Affecting Retained Earnings
0.03
+675.00%
0.00
+0.00%
0.00
+0.00%
0.00
Other Equity Adjustments
0.03
+675.00%
0.00
+0.00%
0.00
+0.00%
0.00
Total Equity Gross Minority Interest
20.90
+1543.30%
-1.45
-117.44%
8.30
-70.39%
28.04
Total Capitalization
30.74
+2222.65%
-1.45
-117.44%
8.30
-80.67%
42.96
Working Capital
29.79
+877.47%
-3.83
-166.85%
5.73
-85.69%
40.04
Invested Capital
30.74
+102.02%
15.21
-37.58%
24.37
-43.27%
42.96
Total Debt
9.96
-40.48%
16.73
+3.29%
16.20
+8.04%
14.99
Net Debt
—
1.17
—
—
Capital Lease Obligations
0.12
+75.36%
0.07
-45.67%
0.13
+73.97%
0.07
Net Tangible Assets
18.89
+613.48%
-3.68
-162.88%
5.85
-76.93%
25.37
Tangible Book Value
18.89
+613.48%
-3.68
-162.88%
5.85
-76.93%
25.37
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-29.77
-21.61%
-24.48
+34.84%
-37.57
-27.61%
-29.44
Cash Flow From Continuing Operating Activities
-29.77
-21.61%
-24.48
+34.84%
-37.57
-27.61%
-29.44
Net Income From Continuing Operations
-39.83
-33.58%
-29.82
+29.60%
-42.35
-27.74%
-33.15
Depreciation Amortization Depletion
0.23
+0.44%
0.23
-3.39%
0.24
-5.60%
0.25
Depreciation
—
—
—
0.03
Amortization Cash Flow
—
—
—
0.22
Depreciation And Amortization
0.23
+0.44%
0.23
-3.39%
0.24
-5.60%
0.25
Amortization Of Intangibles
—
—
—
0.22
Other Non Cash Items
1.81
-26.11%
2.45
+104.60%
1.20
+2817.07%
0.04
Stock Based Compensation
5.33
+54.84%
3.44
+5.17%
3.27
+49.52%
2.19
Operating Gains Losses
0.28
—
—
—
Change In Working Capital
2.41
+410.03%
-0.78
-1084.81%
0.08
-93.60%
1.23
Change In Receivables
0.11
+1950.00%
-0.01
-112.50%
0.05
+131.37%
-0.15
Change In Prepaid Assets
-0.77
-165.05%
1.18
+226.32%
-0.93
-308.33%
-0.23
Change In Payables And Accrued Expense
3.07
+262.28%
-1.89
-295.45%
0.97
-40.64%
1.63
Change In Accrued Expense
1.74
+304.60%
-0.85
-604.76%
0.17
-85.00%
1.12
Change In Payable
1.33
+227.83%
-1.04
-230.41%
0.80
+56.97%
0.51
Change In Account Payable
1.33
+227.83%
-1.04
-230.41%
0.80
+56.97%
0.51
Change In Other Working Capital
—
—
-0.26
-156.44%
0.47
Change In Other Current Liabilities
-0.00
+98.28%
-0.06
-1060.00%
-0.01
+64.29%
-0.01
Investing Cash Flow
-21.58
-102661.90%
-0.02
0.00
0.00
Cash Flow From Continuing Investing Activities
-21.58
-102661.90%
-0.02
0.00
0.00
Net PPE Purchase And Sale
0.00
+100.00%
-0.02
0.00
0.00
Purchase Of PPE
0.00
+100.00%
-0.02
0.00
0.00
Capital Expenditure
—
-0.02
—
—
Net Investment Purchase And Sale
-21.58
0.00
0.00
0.00
Purchase Of Investment
-47.89
0.00
0.00
0.00
Sale Of Investment
26.31
0.00
0.00
0.00
Financing Cash Flow
48.53
+217.63%
15.28
-20.90%
19.32
-47.24%
36.61
Cash Flow From Continuing Financing Activities
48.53
+217.63%
15.28
-20.90%
19.32
-47.24%
36.61
Net Issuance Payments Of Debt
-8.29
0.00
0.00
-100.00%
14.93
Issuance Of Debt
9.81
0.00
0.00
-100.00%
14.93
Repayment Of Debt
-18.11
0.00
0.00
—
Long Term Debt Issuance
9.81
0.00
0.00
-100.00%
14.93
Long Term Debt Payments
-18.11
0.00
0.00
—
Net Long Term Debt Issuance
-8.29
0.00
0.00
-100.00%
14.93
Net Common Stock Issuance
56.08
+267.21%
15.27
-20.51%
19.21
-9.98%
21.34
Common Stock Payments
0.00
+100.00%
-0.03
—
—
Repurchase Of Capital Stock
0.00
+100.00%
-0.03
—
—
Proceeds From Stock Option Exercised
0.86
+278.85%
0.23
+51.33%
0.15
-55.62%
0.34
Net Other Financing Charges
-0.11
+48.18%
-0.22
-368.09%
-0.05
—
Changes In Cash
-2.82
+69.39%
-9.22
+49.48%
-18.25
-354.59%
7.17
Effect Of Exchange Rate Changes
0.00
+100.00%
-0.00
-200.00%
0.00
+400.00%
-0.00
Beginning Cash Position
15.60
-37.17%
24.82
-42.37%
43.07
+19.97%
35.90
End Cash Position
12.77
-18.10%
15.60
-37.17%
24.82
-42.37%
43.07
Free Cash Flow
-29.77
-21.51%
-24.50
+34.79%
-37.57
-27.61%
-29.44
Common Stock Issuance
56.08
+266.49%
15.30
-20.36%
19.21
-9.98%
21.34
Issuance Of Capital Stock
56.08
+266.49%
15.30
-20.36%
19.21
-9.98%
21.34
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category